In this paper, we describe the development of micellar formulations for increasing the solubility of lipophilic benzoporphyrins. Using a simple procedure that is readily adaptable for large-scale manufacturing, both A-ring (1) and B-ring isomers (2) of benzoporphyrins could be readily formulated, at concentrations up to 1-2 mg/ml, into small
micelles (<20 nm in diameter) of methoxypoly(
ethylene glycol) (M(r) 2000) covalently attached to the
lipid anchor distearoylphosphatidylethanolamine (
mPEG-
DSPE). The formulations spontaneously formed upon hydration of a thin film containing
mPEG-
lipid and
photosensitizer and were stable upon storage at 4 degrees C for at least 1 month. Self-association of the B-ring benzoporphyrin isomer in
micelles could be efficiently inhibited by either increasing the molar ratio of
mPEG(2000)-DSPE to benzoporphyrin or by increasing the pH of the preparation to pH 8.5. The formulation could be freeze-dried and stored indefinitely in the lyophilized form, with restoration of the original properties upon reconstitution. In vivo, the A-ring benzoporphyrin,
verteporfin, had higher levels of delivery and greater
tumor control in mice than the B-ring derivative when formulated in
mPEG(2000)-DSPE micelles and administered intravenously.
mPEG(2000)-DSPE micellar formulations also showed
tumor control when administered by a single intratumoral injection followed by light irradiation to the
tumor within 45-60 min after
drug administration. PEG-containing micellar formulations may be a promising delivery system for benzoporphyrin monoesters for clinical applications.